Less basal thyrotropin levels predict antidepressant response in patients with major depression. (1st June 2022)
- Record Type:
- Journal Article
- Title:
- Less basal thyrotropin levels predict antidepressant response in patients with major depression. (1st June 2022)
- Main Title:
- Less basal thyrotropin levels predict antidepressant response in patients with major depression
- Authors:
- Navinés, R.
Oriolo, G.
Mora, M.
Cavero, M.
Gómez-Gil, E.
Martin-Santos, R. - Abstract:
- Abstract : Introduction: The close association among thyroid metabolism, mood disorders and behavior has long been known. The role of basal thyroid axis in antidepressant treatment response is less known. Objectives: The aim of the present study was to study the association of basal serum thyrotropin (TSH) levels, with antidepressant treatment response in major depressive disorder. Methods: Thirty-one depressed adult outpatients were included. Major depressive episode was diagnosed through the MINI (DSM-IV-TR) interview. Clinical symptomatology and blood samples were assessed at baseline, and at 4- and 8-weeks of either escitalopram or sertraline. Treatment response was defined by an improvement ≥50% in MADRS scores at 4-, and 8-weeks. Basal TSH levels were included in a linear regression model as predictor of treatment response. Results: Twenty-seven patients finished 8-weeks of treatment. Response to treatment was of 74% at 4-weeks, and 63% at 8-weeks of antidepressant treatment. Basal median TSH levels were between normal ranges (M+ SD=1.85+ 1, 02 mlU/L). Basal TSH levels not correlated with basal MADRS scores, but with higher MADRS scores at week-4 (r=0, 415, p=0, 031) and at week-8 (r=0, 392, p=0, 043). Moreover, less baseline TSH levels trend to be a significant good predictor for treatment response at 4-weeks (R 2 =.116, p=.083); and a good predictor at 8-weeks treatment (R 2 =.147, p=.049). Conclusions: Baseline TSH levels even within the normal range may play a roleAbstract : Introduction: The close association among thyroid metabolism, mood disorders and behavior has long been known. The role of basal thyroid axis in antidepressant treatment response is less known. Objectives: The aim of the present study was to study the association of basal serum thyrotropin (TSH) levels, with antidepressant treatment response in major depressive disorder. Methods: Thirty-one depressed adult outpatients were included. Major depressive episode was diagnosed through the MINI (DSM-IV-TR) interview. Clinical symptomatology and blood samples were assessed at baseline, and at 4- and 8-weeks of either escitalopram or sertraline. Treatment response was defined by an improvement ≥50% in MADRS scores at 4-, and 8-weeks. Basal TSH levels were included in a linear regression model as predictor of treatment response. Results: Twenty-seven patients finished 8-weeks of treatment. Response to treatment was of 74% at 4-weeks, and 63% at 8-weeks of antidepressant treatment. Basal median TSH levels were between normal ranges (M+ SD=1.85+ 1, 02 mlU/L). Basal TSH levels not correlated with basal MADRS scores, but with higher MADRS scores at week-4 (r=0, 415, p=0, 031) and at week-8 (r=0, 392, p=0, 043). Moreover, less baseline TSH levels trend to be a significant good predictor for treatment response at 4-weeks (R 2 =.116, p=.083); and a good predictor at 8-weeks treatment (R 2 =.147, p=.049). Conclusions: Baseline TSH levels even within the normal range may play a role in predicting antidepressant response. Disclosure: No significant relationships. … (more)
- Is Part Of:
- European psychiatry. Volume 65:Supplement 1(2022)
- Journal:
- European psychiatry
- Issue:
- Volume 65:Supplement 1(2022)
- Issue Display:
- Volume 65, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 65
- Issue:
- 1
- Issue Sort Value:
- 2022-0065-0001-0000
- Page Start:
- S257
- Page End:
- S258
- Publication Date:
- 2022-06-01
- Subjects:
- tirotrophin -- major depression -- antidepressant response -- MADRS
Psychiatry -- Periodicals
Mental illness -- Periodicals
Electronic journals
616.89 - Journal URLs:
- https://www.cambridge.org/core/journals/european-psychiatry ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09249338 ↗
http://www.sciencedirect.com/science/journal/09249338 ↗
http://www.elsevier.com/homepage/elecserv.htt ↗ - DOI:
- 10.1192/j.eurpsy.2022.662 ↗
- Languages:
- English
- ISSNs:
- 0924-9338
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.842700
British Library HMNTS - ELD Digital store - Ingest File:
- 23301.xml